Preoperative hematocrit levels and postoperative mortality in patients undergoing craniotomy for brain tumors.

anemia brain tumor craniotomy hematocrit mortality polycythemia

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 24 06 2023
accepted: 02 10 2023
medline: 2 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: epublish

Résumé

Abnormal hematocrit values, including anemia and polycythemia, are common in patients undergoing craniotomy, but the extent to which preoperative anemia or polycythemia independently increases the risk of mortality is unclear. This retrospective cohort study aimed to examine the association between preoperative anemia and polycythemia and postoperative mortality in patients who underwent craniotomy for brain tumor resection. We retrospectively analyzed data from 12,170 patients diagnosed with a brain tumor who underwent cranial surgery at West China Hospital between January 2011 and March 2021. The preoperative hematocrit value was defined as the last hematocrit value within 7 days before the operation, and patients were grouped according to the severity of their anemia or polycythemia. We assessed the primary outcome of 30-day postoperative mortality using logistic regression analysis adjusted for potential confounding factors. Multivariable logistic regression analysis reported that the 30-day mortality risk was raised with increasing severity of both anemia and polycythemia. Odds ratios for mild, moderate, and severe anemia were 1.12 (95% CI: 0.79-1.60), 1.66 (95% CI: 1.06-2.58), and 2.24 (95% CI: 0.99-5.06), respectively. Odds ratios for mild, moderate, and severe polycythemia were 1.40 (95% CI: 0.95-2.07), 2.81 (95% CI: 1.32-5.99), and 14.32 (95% CI: 3.84-53.44), respectively. This study demonstrated that moderate to severe anemia and polycythemia are independently associated with increased postoperative mortality in patients undergoing craniotomy for brain tumor resection. These findings underscore the importance of identifying and managing abnormal hematocrit values before craniotomy surgery.

Sections du résumé

Background UNASSIGNED
Abnormal hematocrit values, including anemia and polycythemia, are common in patients undergoing craniotomy, but the extent to which preoperative anemia or polycythemia independently increases the risk of mortality is unclear. This retrospective cohort study aimed to examine the association between preoperative anemia and polycythemia and postoperative mortality in patients who underwent craniotomy for brain tumor resection.
Methods UNASSIGNED
We retrospectively analyzed data from 12,170 patients diagnosed with a brain tumor who underwent cranial surgery at West China Hospital between January 2011 and March 2021. The preoperative hematocrit value was defined as the last hematocrit value within 7 days before the operation, and patients were grouped according to the severity of their anemia or polycythemia. We assessed the primary outcome of 30-day postoperative mortality using logistic regression analysis adjusted for potential confounding factors.
Results UNASSIGNED
Multivariable logistic regression analysis reported that the 30-day mortality risk was raised with increasing severity of both anemia and polycythemia. Odds ratios for mild, moderate, and severe anemia were 1.12 (95% CI: 0.79-1.60), 1.66 (95% CI: 1.06-2.58), and 2.24 (95% CI: 0.99-5.06), respectively. Odds ratios for mild, moderate, and severe polycythemia were 1.40 (95% CI: 0.95-2.07), 2.81 (95% CI: 1.32-5.99), and 14.32 (95% CI: 3.84-53.44), respectively.
Conclusions UNASSIGNED
This study demonstrated that moderate to severe anemia and polycythemia are independently associated with increased postoperative mortality in patients undergoing craniotomy for brain tumor resection. These findings underscore the importance of identifying and managing abnormal hematocrit values before craniotomy surgery.

Identifiants

pubmed: 37916178
doi: 10.3389/fonc.2023.1246220
pmc: PMC10616849
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1246220

Informations de copyright

Copyright © 2023 Xiao, Cheng, Jia, Tian, He, He, Chen, Hao, Li, Chong, Hai, You, Peng, Fang and Zhang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Intern Med. 1994 Feb;235(2):163-8
pubmed: 8308479
Front Pediatr. 2022 Jan 21;9:762241
pubmed: 35127586
Ann Surg. 2013 Dec;258(6):1096-102
pubmed: 23511839
Am J Kidney Dis. 2006 Jan;47(1):24-36
pubmed: 16377382
Front Neurol. 2023 Feb 21;14:1059401
pubmed: 36895901
Haematologica. 2022 May 01;107(5):1106-1110
pubmed: 34162181
Cerebrovasc Dis. 2005;19(4):279-80
pubmed: 15761220
N Engl J Med. 1963 Dec 5;269:1226-30
pubmed: 14060567
Br J Anaesth. 2014 Sep;113(3):416-23
pubmed: 24829444
Expert Rev Hematol. 2023 Jul-Dec;16(7):553-559
pubmed: 37249134
J Neurosurg. 2015 Nov;123(5):1247-55
pubmed: 26053457
N Engl J Med. 2017 Sep 28;377(13):1261-1272
pubmed: 28953438
Surg Neurol Int. 2014 Oct 31;5:156
pubmed: 25422784
Eur Heart J. 2019 Apr 1;40(13):1081-1088
pubmed: 30107514
J Am Coll Cardiol. 2009 Nov 24;54(22):2093-100
pubmed: 19926019
J Neurosurg. 2019 Apr 05;132(5):1529-1538
pubmed: 30952120
Psychother Psychosom. 2022;91(1):8-35
pubmed: 34991091
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Asian Cardiovasc Thorac Ann. 2016 Feb;24(2):175-7
pubmed: 25193984
JAMA. 2007 Jun 13;297(22):2481-8
pubmed: 17565082
Int J Epidemiol. 2013 Apr;42(2):601-15
pubmed: 23569195
World Health Organ Tech Rep Ser. 1968;405:5-37
pubmed: 4975372
Neurosurgery. 2004 Mar;54(3):553-63; discussion 563-5
pubmed: 15028128
Can J Surg. 2022 Jan 18;65(1):E25-E37
pubmed: 35042718
J Neurosurg. 2014 Mar;120(3):764-72
pubmed: 24286148
Am J Epidemiol. 2008 Aug 15;168(4):355-7
pubmed: 18591202
Front Pharmacol. 2021 May 11;12:680636
pubmed: 34045970
Anesth Analg. 2021 Nov 1;133(5):1077-1088
pubmed: 33721876
J Arthroplasty. 2020 Jun;35(6S):S133-S137
pubmed: 31776052

Auteurs

Yangchun Xiao (Y)

Department of Neurosurgery, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.

Xin Cheng (X)

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Lu Jia (L)

Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.

Yixin Tian (Y)

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Jialing He (J)

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Miao He (M)

Department of Anesthesia, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.

Lvlin Chen (L)

Department of Critical Care Medicine, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.

Pengfei Hao (P)

Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.

Tiangui Li (T)

Department of Neurosurgery, Longquan Hospital, Chengdu, Sichuan, China.

Weelic Chong (W)

Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States.

Yang Hai (Y)

Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.

Chao You (C)

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Liyuan Peng (L)

Department of Critical Care Medicine, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.

Fang Fang (F)

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Yu Zhang (Y)

Center for Evidence Based Medical, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.

Classifications MeSH